Hydroxycarbamide for very young children with sickle cell anaemia: No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

Deepa Manwani

doi:10.1136/ebm.2011.100104

Hydroxycarbamide for very young children with sickle cell anaemia: No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

Deepa Manwani

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	37-38
Number of pages	2
Journal	Evidence-Based Medicine
Volume	17
Issue number	2
DOIs	https://doi.org/10.1136/ebm.2011.100104
State	Published - Apr 2012

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/ebm.2011.100104

Cite this

@article{81c32d86b4a748ccba204fa9a537917b,

title = "Hydroxycarbamide for very young children with sickle cell anaemia: No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity",

author = "Deepa Manwani",

year = "2012",

month = apr,

doi = "10.1136/ebm.2011.100104",

language = "English (US)",

volume = "17",

pages = "37--38",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Hydroxycarbamide for very young children with sickle cell anaemia

T2 - No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

AU - Manwani, Deepa

PY - 2012/4

Y1 - 2012/4

UR - http://www.scopus.com/inward/record.url?scp=84859445313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859445313&partnerID=8YFLogxK

U2 - 10.1136/ebm.2011.100104

DO - 10.1136/ebm.2011.100104

M3 - Comment/debate

C2 - 21891796

AN - SCOPUS:84859445313

SN - 1356-5524

VL - 17

SP - 37

EP - 38

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

IS - 2

ER -

Hydroxycarbamide for very young children with sickle cell anaemia: No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this